Evio Pharmacy Solutions, LLC
Formerly KENT PHARMACY NEWCO, LLC
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Feb 2025 | $9 M | No. 1 | $2 to $10 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Evio Pharmacy Solutions, LLC had revenue between $5 million and $25 million when it filed its newest notice of a funding round (Mar 2025).
SEC Form D (revenue range) · Mar 2025
The industry group it chose in its notices: Other Health Care.
SEC Form D · Mar 2025
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Evio Pharmacy Solutions, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Hank Schlissberg | Executive officer | Mar 2025 |
| Helen E. Sherman | Executive officer | Mar 2025 |
| Jeffrey A. Williams | Executive officer | Mar 2025 |
| Deborah L. Johnson | Director | Mar 2025 |
| Juan A. Lopez | Director | Mar 2025 |
| Richard E. Lynch | Director | Mar 2025 |
| Susan E. Mullaney | Director | Mar 2025 |
| Todd E. Van Tol | Director | Mar 2025 |